China Resources Sanjiu to repurchase and cancel shares

China Resources Sanjiu Medical & Pharmaceutical announced it will repurchase and cancel 5,333,927 shares, representing approximately 0.32% of its share capital, due to terminations, retirements, and unmet performance targets of participants in its 2021 restricted stock incentive plan. The decision was approved at a shareholder meeting on July 7, 2025. The company is notifying creditors, who have 45 days to claim debt repayment or guarantees. This repurchase will reduce the total share capital from 1,669,588,290 to 1,664,254,363 shares, with subsequent registration changes to follow.